financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Retains Buy Opinion On Shares Of The Goldman Sachs Group, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Retains Buy Opinion On Shares Of The Goldman Sachs Group, Inc.
May 7, 2024 12:22 PM

02:50 PM EDT, 05/07/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our target by $38 to $488 on a forward P/E of 12.8x, a premium to the three-year normalized P/E of 12.0x given our view that GS is revamping the businesses to more durable and recurring fee income. The areas of opportunity and growth lie within Asset & Wealth Management, specifically the alternative assets under supervision (AUS), which totaled $296B, and GS plans to raise another $40B-$50B in 2024. Private credit is a specific area for future growth and totaled $114B AUS at year-end. We also think the capital markets for equity underwriting and M&A are beginning to improve to complement the strong growth seen in Q1 for debt underwriting. We think Global Banking Markets will gain wallet share in North America and EMEA. CEO confidence is rising, which is a positive sign for corporate capital raising, while financial sponsors (ALT firms) have significant buyout companies that need to be monetized for limited partners in order to do new fundraising. GS has a "through-the-cycle" target of 15%-17% ROE.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Shares Of Cvs Health Corporation
Research Alert: CFRA Keeps Hold Opinion On Shares Of Cvs Health Corporation
May 26, 2025
11:15 AM EDT, 05/02/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target by $7 to $76, based on a 12.4x multiple of our 2025 EPS estimate, a premium to peers due to a higher return on invested...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Air Products And Chemicals, Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Air Products And Chemicals, Inc.
May 26, 2025
10:15 AM EDT, 05/02/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We decrease our 12-month target by $32 to $337, or 25.0x our FY 26 (Sep.) EPS estimate, above APD's three-year avg. forward P/E of 22.6x, which we think is warranted...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Linde Plc
Research Alert: CFRA Maintains Hold Opinion On Shares Of Linde Plc
May 26, 2025
10:30 AM EDT, 05/02/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We decrease our 12-month target price by $20 to $473, or 25.0x our 2026 EPS estimate, a small discount to LIN's three-year average forward P/E of 26.6x, but in line...
Research Alert: CFRA Lowers Opinion On Shares Of Dolby Laboratories, Inc. To Sell From Hold
Research Alert: CFRA Lowers Opinion On Shares Of Dolby Laboratories, Inc. To Sell From Hold
May 26, 2025
10:50 AM EDT, 05/02/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our price target by $24 to $65, utilizing a P/E ratio of 16.5x applied to our FY 25 (Sep.) EPS estimate of $3.94. This multiple is below DLB's...
Copyright 2023-2026 - www.financetom.com All Rights Reserved